Frontlight ResearchEarly access
Trial site
Velocity Clinical Research Germany GmbH
- 14running trials
- 10closed trials
The trials here
What the 24 trials at this site are about, from their registry records.
- Conditions
- COPD8 trials
- Asthma7 trials
- Bronchiectasis3 trials
- Cystic fibrosis2 trials
- Chronic kidney disease1 trial
- Depression1 trial
- Idiopathic pulmonary fibrosis1 trial
- Irritable bowel syndrome1 trial
- Long COVID and ME/CFS1 trial
- Phase
- Phase 28 trials
- Phase 38 trials
- Phase 14 trials
- Phase 43 trials
- Phase 2/31 trial
- Status
- Completed10 trials
- Recruiting7 trials
- Active, not recruiting6 trials
- Not yet recruiting1 trial
- Lead sponsor
- AstraZeneca6 trials
- GlaxoSmithKline3 trials
- Sanofi3 trials
- AstraZeneca AB2 trials
- Boehringer Ingelheim2 trials
- and 7 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- COPD4 recruiting
- Bronchiectasis1 recruiting
- Chronic kidney disease1 recruiting
- Cystic fibrosis1 recruiting
- Irritable bowel syndrome1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Mechanistic Study of the Effect of Itepekimab on Airway Inflammation in Patients With COPD
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026